Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions. [electronic resource]
Producer: 20130624Description: 127-36 p. digitalISSN:- 2567-689X
- Administration, Oral
- Anticoagulants -- administration & dosage
- Arthroplasty, Replacement, Hip -- adverse effects
- Arthroplasty, Replacement, Knee -- adverse effects
- Biomarkers -- blood
- Blood Coagulation -- drug effects
- Blood Coagulation Factors -- antagonists & inhibitors
- Blood Coagulation Tests -- methods
- Chromatography, High Pressure Liquid
- Chromogenic Compounds
- Drug Administration Schedule
- Enzyme-Linked Immunosorbent Assay
- Factor Xa -- metabolism
- Factor Xa Inhibitors
- False Positive Reactions
- Humans
- Morpholines -- administration & dosage
- Nephelometry and Turbidimetry
- Predictive Value of Tests
- Reproducibility of Results
- Rivaroxaban
- Tablets
- Tandem Mass Spectrometry
- Thiophenes -- administration & dosage
- Thrombophilia -- blood
- Thrombosis -- blood
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.